Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2019-01-29
2019-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Phytochemicals on Aspects of Cognitive Performance
NCT02167750
Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers
NCT04281758
Investigation of Acute Mood and Cognitive Performance Effects of Beverages Containing Phenolics in Healthy Adults
NCT02675621
Nutrient-Fortified Beverage Study
NCT02103192
Effect of Energy Drink on Sport Performance and Psycho-Physiological Responses.
NCT03936712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavored Beverage Mix 1
Flavored still beverage
Flavored beverage
Consume one beverage at the beginning of each visit of the cross-over sequence
Flavored Beverage Mix 2
Flavored still beverage with polyphenols, concentration 1
Flavored beverage
Consume one beverage at the beginning of each visit of the cross-over sequence
Flavored Beverage Mix 3
Flavored still beverage with polyphenols, concentration 2
Flavored beverage
Consume one beverage at the beginning of each visit of the cross-over sequence
Flavored Beverage Mix 4
Flavored still beverage with caffeine
Flavored beverage
Consume one beverage at the beginning of each visit of the cross-over sequence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavored beverage
Consume one beverage at the beginning of each visit of the cross-over sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-report of good health
* Physical activity requirement: Recreationally active (exercise ≥3 times per week for \>30 minutes per session; both cyclists and non-cyclists may enroll)
Exclusion Criteria
* Visual impairment that cannot be corrected with glasses or contact lenses
* Inability to perform high intensity exercise (defined perceptually as exercise that feels at least "hard" and this is usually quantified using the Borg 6 to 20 scale. High intensity cycling exercise is defined objectively as exercise causing a high heart rate, defined as a heart rate that is equal to or greater than 70% of heart rate reserve.)
* Inability to adequately perform the cognitive tasks (i.e., cannot complete the task due to -inability to understand instructions or \>50% incorrect responses)
* Presence of current or chronic gastrointestinal, sleep or psychiatric disorder
* Pregnant/lactating
* Current smoker
* Report illegal drug use
* Report hypersensitivity to caffeine
* Food allergies/intolerances/sensitivities (including coffee or related foods/beverages/products)
* Current use of dietary supplements, or prescription medication except for oral contraceptives
* Unwillingness to abstain from over the counter medications (e.g. NSAIDS, allergy medications) and caffeine/coffee/foods high in polyphenols for 12 hours prior to the study
* Unwilling to refrain from consuming apple and grapefruit products on study days and 12 hours prior to test days.
* Participation in another clinical trial within the past 30 days or participation in another PepsiCo trial in the past 6 months
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PepsiCo Global R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick J O'Connor, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Georgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Georgia
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEP-1807
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.